Correlation Between Haleon Plc and Rapport Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Haleon Plc and Rapport Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Haleon Plc and Rapport Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Haleon plc and Rapport Therapeutics, Common, you can compare the effects of market volatilities on Haleon Plc and Rapport Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Haleon Plc with a short position of Rapport Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Haleon Plc and Rapport Therapeutics,.
Diversification Opportunities for Haleon Plc and Rapport Therapeutics,
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Haleon and Rapport is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Haleon plc and Rapport Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rapport Therapeutics, and Haleon Plc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Haleon plc are associated (or correlated) with Rapport Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rapport Therapeutics, has no effect on the direction of Haleon Plc i.e., Haleon Plc and Rapport Therapeutics, go up and down completely randomly.
Pair Corralation between Haleon Plc and Rapport Therapeutics,
Considering the 90-day investment horizon Haleon Plc is expected to generate 2.91 times less return on investment than Rapport Therapeutics,. But when comparing it to its historical volatility, Haleon plc is 6.34 times less risky than Rapport Therapeutics,. It trades about 0.11 of its potential returns per unit of risk. Rapport Therapeutics, Common is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 2,080 in Rapport Therapeutics, Common on September 3, 2024 and sell it today you would earn a total of 320.00 from holding Rapport Therapeutics, Common or generate 15.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 98.4% |
| Values | Daily Returns |
Haleon plc vs. Rapport Therapeutics, Common
Performance |
| Timeline |
| Haleon plc |
| Rapport Therapeutics, |
Haleon Plc and Rapport Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Haleon Plc and Rapport Therapeutics,
The main advantage of trading using opposite Haleon Plc and Rapport Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Haleon Plc position performs unexpectedly, Rapport Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rapport Therapeutics, will offset losses from the drop in Rapport Therapeutics,'s long position.| Haleon Plc vs. Teva Pharma Industries | Haleon Plc vs. Bausch Health Companies | Haleon Plc vs. Zoetis Inc | Haleon Plc vs. Takeda Pharmaceutical Co |
| Rapport Therapeutics, vs. Copa Holdings SA | Rapport Therapeutics, vs. Aegean Airlines SA | Rapport Therapeutics, vs. Ituran Location and | Rapport Therapeutics, vs. Grupo Televisa SAB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Transaction History View history of all your transactions and understand their impact on performance |